Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
about
The Vpr protein from HIV-1: distinct roles along the viral life cycleVirological and cellular roles of the transcriptional coactivator LEDGF/p75The connection domain in reverse transcriptase facilitates the in vivo annealing of tRNALys3 to HIV-1 genomic RNAContribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear importDistribution and Redistribution of HIV-1 Nucleocapsid Protein in Immature, Mature, and Integrase-Inhibited Virions: a Role for Integrase in MaturationEngineered hyperactive integrase for concerted HIV-1 DNA integrationDriving DNA transposition by lentiviral protein transductionEmergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.Fluorescent protein-tagged Vpr dissociates from HIV-1 core after viral fusion and rapidly enters the cell nucleus.The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication.Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.Pathogenesis of HIV-1 infection within bone marrow cells.Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex.Analysis of the contribution of reverse transcriptase and integrase proteins to retroviral RNA dimer conformation.Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase.Production of uninfectious human immunodeficiency virus type 1 containing viral protein R fused to a single-chain antibody against viral integrase.Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.Effect of polypurine tract (PPT) mutations on human immunodeficiency virus type 1 replication: a virus with a completely randomized PPT retains low infectivity.Integrase-lexA fusion proteins incorporated into human immunodeficiency virus type 1 that contains a catalytically inactive integrase gene are functional to mediate integrationTargeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1.Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1.Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells.Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activityTy3 integrase is required for initiation of reverse transcriptionCoding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cellsThe level of reverse transcriptase (RT) in human immunodeficiency virus type 1 particles affects susceptibility to nonnucleoside RT inhibitors but not to lamivudineSubunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.Cyclophilin a plays distinct roles in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculation.The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells.Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): naturally selected mutations in IN augment DNA synthesis.Evidence for biphasic uncoating during HIV-1 infection from a novel imaging assay.Integrase, LEDGF/p75 and HIV replication.
P2860
Q21245211-E5184057-3273-4B91-A76F-701F3E23FCF3Q24634176-803D5C64-B6FD-45F8-BD0A-A7E143AA403FQ24806162-AA371B8D-E725-4919-99F6-148DD6E9981BQ24814060-3FB01E54-20FF-466D-B6D2-71016B6D5048Q27321347-B4A5319E-FF52-49E8-A2F4-1D8D828B0EF2Q28541856-DE7DE378-5F0C-4239-8D15-552B030BABD3Q28655839-D2A5C409-0703-47DB-89AE-B7507362E56BQ29619254-829754FC-DEE4-4732-B98A-ACD29215D2D7Q30671100-638DEC0C-FD3D-4C5B-A142-9B8F95E1CD14Q33325927-C6173152-0F4B-45A6-AE39-9A731DC6FE89Q33328499-C89DC3D6-C42A-4D13-9902-59D108C7380FQ33334766-A2BA3E15-DB23-4903-9819-C1570FD34FD6Q33653264-44E80667-4D6E-4B48-BAB4-93C6E372C0CEQ33780519-CBF2C91C-1004-4CD3-B86F-E644C0D662F3Q33782016-5D4A80BC-61AE-47B9-9D02-163DB4C69FA3Q33783708-6164EE02-299B-4E2C-BDB7-3E1F0CB1937BQ33784907-F837ABC8-10F9-4C10-9B0E-5F2559FEB144Q33788773-BC0B229C-BD6F-44EC-BABE-CACA880DE2E4Q33812392-42F55CEA-D889-45FD-BD4A-300B7BFCE28EQ33821401-76184C01-571A-45DF-A042-E0B359CB0E06Q33837707-CB7BFE4B-EF98-42AC-8957-7F71689B194EQ33838311-F2244550-5131-44B5-9CA6-590AAE400921Q33844166-E522D292-4B19-4827-B9D1-F94276413927Q33849672-1E55EC97-243C-43E1-BF63-48417D4896EDQ33911895-289CB344-CE0E-414A-92D6-1353E94D27DCQ33935269-C9C8F6AB-57FF-4675-8DD0-F035B4C270FFQ34331870-3CC10D80-0D74-4002-A66B-5D672B63147DQ34332190-046D6E4C-6AA3-449D-9B4F-E53780526129Q34334594-D689D411-FB53-478F-95AA-98A4633D8832Q34353549-BB6132A6-302B-46B5-AEED-2FE0473EA2CAQ34434653-6F15AEB6-D942-4D51-B84E-FE8AA9B7C630Q34438247-41827CB5-70A1-4917-8574-BD58222DF21EQ34991047-B9258B06-572B-4E14-ADB3-E1CDBCA89449Q34999443-A46CF05D-AB1E-4F7F-AE65-168427FCA0F7Q34999802-3C2F00BF-EA78-4734-99EC-AFA970479897Q35895836-B8338143-BBEB-4841-AF67-AA1D376BA9BDQ35916117-0D51567C-D8D6-4D21-8AF7-B869E25F8F7CQ36473812-EC148E20-BE38-46D9-9BC8-619B348C4591Q37028427-77713D91-3B05-411B-87B5-A05A5388B0ADQ37081043-BA9B44C1-B979-4C5F-865E-D451B4D39E1C
P2860
Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Functional RT and IN incorpora ...... the Gag/Pol precursor protein.
@ast
Functional RT and IN incorpora ...... the Gag/Pol precursor protein.
@en
type
label
Functional RT and IN incorpora ...... the Gag/Pol precursor protein.
@ast
Functional RT and IN incorpora ...... the Gag/Pol precursor protein.
@en
prefLabel
Functional RT and IN incorpora ...... the Gag/Pol precursor protein.
@ast
Functional RT and IN incorpora ...... the Gag/Pol precursor protein.
@en
P2093
P2860
P356
P1433
P1476
Functional RT and IN incorpora ...... the Gag/Pol precursor protein.
@en
P2093
P2860
P304
P356
10.1093/EMBOJ/16.16.5113
P407
P577
1997-08-01T00:00:00Z